{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:34:26Z","timestamp":1777883666940,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M700504"],"award-info":[{"award-number":["2021M700504"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672559"],"award-info":[{"award-number":["81672559"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077115"],"award-info":[{"award-number":["22077115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104231"],"award-info":[{"award-number":["82104231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bmcl.2022.128952","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T18:57:45Z","timestamp":1661540265000},"page":"128952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of the gossypol derivatives as androgen receptor inhibitor"],"prefix":"10.1016","volume":"75","author":[{"given":"Rongyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongxiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangjiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifa","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128952_b0005","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2022.128952_b0010","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bmcl.2022.128952_b0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5534\/wjmh.180040","article-title":"Role of androgen receptor in prostate cancer: a review","volume":"37","author":"Fujita","year":"2019","journal-title":"World J Mens Health"},{"key":"10.1016\/j.bmcl.2022.128952_b0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajur.2020.03.002","article-title":"Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer","volume":"7","author":"Narayanan","year":"2020","journal-title":"Asian J Urol"},{"key":"10.1016\/j.bmcl.2022.128952_b0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/13543784.2018.1484107","article-title":"Apalutamide: the established and emerging roles in the treatment of advanced prostate cancer","volume":"27","author":"Dellis","year":"2018","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmcl.2022.128952_b0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eururo.2017.09.038","article-title":"Antitumor activity and safety of enzalutamide after abiraterone acetate: seeking the optimal treatment sequence for castration-resistant prostate cancer patients","volume":"74","author":"Saito","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.bmcl.2022.128952_b0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128952_b0040","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1158\/2159-8290.CD-13-0226","article-title":"A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509","volume":"3","author":"Joseph","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bmcl.2022.128952_b0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrurol.2014.243","article-title":"Emerging mechanisms of enzalutamide resistance in prostate cancer","volume":"11","author":"Claessens","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.bmcl.2022.128952_b0050","doi-asserted-by":"crossref","first-page":"18550","DOI":"10.18632\/oncotarget.14537","article-title":"Androgen receptor splice variants and prostate cancer: from bench to bedside","volume":"8","author":"Wadosky","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2022.128952_b0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.urolonc.2015.11.003","article-title":"Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: a review","volume":"34","author":"Anantharaman","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.bmcl.2022.128952_b0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3389\/fonc.2019.00858","article-title":"Androgen receptor signaling in the development of castration-resistant prostate cancer","volume":"9","author":"Feng","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2022.128952_b0065","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/13543784.14.11.1419","article-title":"Investigations on gossypol: past and present developments","volume":"14","author":"Dodou","year":"2005","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmcl.2022.128952_b0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/13880209.2013.832776","article-title":"Therapeutic potential of gossypol: an overview","volume":"52","author":"Keshmiri-Neghab","year":"2014","journal-title":"Pharm Biol"},{"key":"10.1016\/j.bmcl.2022.128952_b0075","first-page":"1925","article-title":"Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells","volume":"26","author":"Huang","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bmcl.2022.128952_b0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1535-7163.MCT-11-0559","article-title":"Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation","volume":"11","author":"Lian","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2022.128952_b0085","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jcb.22633","article-title":"AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model","volume":"110","author":"McGregor","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bmcl.2022.128952_b0090","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/1535-7163.MCT-08-0333","article-title":"Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa","volume":"7","author":"Meng","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2022.128952_b0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1535-7163.MCT-10-0936","article-title":"(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis","volume":"10","author":"Pang","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2022.128952_b0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3835(96)04340-6","article-title":"Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta","volume":"107","author":"Shidaifat","year":"1996","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmcl.2022.128952_b0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/1535-7163.MCT-09-0507","article-title":"Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells","volume":"9","author":"Volate","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2022.128952_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1535-7163.197.4.2","article-title":"(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer","volume":"4","author":"Xu","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmcl.2022.128952_b0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.fitote.2018.12.024","article-title":"Gossypol inhibits 5alpha-reductase 1 and 3alpha-hydroxysteroid dehydrogenase: its possible use for the treatment of prostate cancer","volume":"133","author":"Cao","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmcl.2022.128952_b0120","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1021\/jm060460o","article-title":"Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins","volume":"49","author":"Wang","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0125","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1021\/jm9002507","article-title":"The immobilization of gossypol derivative on N-polyvinylpyrrolidone increases its water solubility and modifies membrane-active properties","volume":"52","author":"Ionov","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0130","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1021\/jm1001698","article-title":"A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer","volume":"53","author":"Yan","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0135","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.ejmech.2009.04.025","article-title":"Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling","volume":"44","author":"Zhang","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0140","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/acs.jafc.0c06058","article-title":"Synthesis and anti-tobacco mosaic virus\/fungicidal\/insecticidal\/antitumor bioactivities of natural product hemigossypol and its derivatives","volume":"69","author":"Li","year":"2021","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0145","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1002\/anie.201801612","article-title":"Cascade Claisen rearrangement: rapid synthesis of polysubstituted salicylaldehydes and total syntheses of hemigossypol and gossypol","volume":"57","author":"Cao","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmcl.2022.128952_b0150","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2022.128952_b0155","first-page":"57","article-title":"Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance","volume":"6","author":"Tian","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2022.128952_b0160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.jmedchem.8b01631","article-title":"Discovery of ARD-69 as a highly potent proteolysis targeting chimera (PROTAC) degrader of androgen receptor (AR) for the treatment of prostate cancer","volume":"62","author":"Han","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0165","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1021\/acs.jmedchem.9b01393","article-title":"Discovery of highly potent and efficient PROTAC degraders of androgen receptor (AR) by employing weak binding affinity VHL E3 ligase ligands","volume":"62","author":"Han","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0170","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1021\/acs.jmedchem.8b00502","article-title":"Down-regulation of the androgen receptor by G-Quadruplex ligands sensitizes castration-resistant prostate cancer cells to enzalutamide","volume":"61","author":"Tassinari","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128952_b0175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.4070","article-title":"ROR-gamma drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer","volume":"22","author":"Wang","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2022.128952_b0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1541-7786.MCR-15-0472","article-title":"BET bromodomain inhibitors enhance efficacy and disrupt resistance to AR antagonists in the treatment of prostate cancer","volume":"14","author":"Asangani","year":"2016","journal-title":"Mol Cancer Res : MCR"},{"key":"10.1016\/j.bmcl.2022.128952_b0185","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1038\/s41388-019-0696-7","article-title":"Suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis","volume":"38","author":"Luna Velez","year":"2019","journal-title":"Oncogene"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22004280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22004280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:53:53Z","timestamp":1777600433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22004280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":37,"alternative-id":["S0960894X22004280"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128952","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the gossypol derivatives as androgen receptor inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128952"}}